FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies

Thread starter International: Top News And Analysis
Start date Apr 30, 2026

International: Top News And Analysis

Guest

Apr 30, 2026

If that proposal is finalized, the exclusion would likely limit the mass compounding of those medicines unless they appear on the FDA's ⁠drug shortage ⁠list.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: FDA proposes excluding Novo, Lilly weight loss drugs from bulk compounding list in win for the companies

Prefix: N/A

Forum: World News

Start date: Apr 30, 2026

Last reply date: Apr 30, 2026

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Apr 30, 2026

Replies: 0

Views: 9

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search